Synthesis and anticancer activity evaluation of novel azacalix[2]arene[2]pyrimidines

Add time:08/06/2019    Source:sciencedirect.com

A series of novel azacalix[2]arene[2]pyrimidines were synthesized, and evaluated for their antiproliferative activities against A549, MCF7, SH-SY5Y and CNE human cancer cell lines in vitro by using the CCK-8 assay. A number of compounds showed low micromolar antiproliferative activities against MCF7 cell line. Compound 4j, containing a pyrrolidine moiety, exhibited the strongest inhibitory activity with an IC50 value of 0.58 μM. Furthermore, breast cancer cells were used to explore the inhibition mechanism of these azacalix[2]arene[2]pyrimidines. The results suggested these compounds were involved in inducing cell apoptosis via up-regulation of caspase-3 and caspase-9 protein expression, and the cell cycle was arrested at the S phase. Our reports here represent the first studies on the biological activities of azacalix[2]arene[2]pyrimidines.

We also recommend Trading Suppliers and Manufacturers of 2-(2,4-Dichloro-5-nitrophenyl)-1,2-dihydro-5-methyl-3H-1,2,4-triazol-3-one (cas 100563-34-6). Pls Click Website Link as below: cas 100563-34-6 suppliers

Prev:2-Nitrodiphenylalkanes/alkenes as adept photosynthons for direct access to valuable N-heterocycles
Next:Novel poly(2-oxazoline) block copolymer with aromatic heterocyclic side chains as a drug delivery platform)